Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, GVHD, ATG, Transplantation”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Testing effectiveness (Phase 2)WithdrawnNCT03602898
What this trial is testing

Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic Leukemia+10 more
Fred Hutchinson Cancer Center
Post-approval studies (Phase 4)Study completedNCT01856803
What this trial is testing

Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis

Who this might be right for
Leukemia, GVHD, ATG, Transplantation
Peking University People's Hospital 300
Large-scale testing (Phase 3)Study completedNCT01295710
What this trial is testing

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Who this might be right for
GVHDAdult Acute Myeloid LeukemiaAdult Acute Lymphoid Leukemia+1 more
Neovii Biotech 260
Testing effectiveness (Phase 2)Study completedNCT00691015
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Barbara Ann Karmanos Cancer Institute 48
Testing effectiveness (Phase 2)Looking for participantsNCT06984536
What this trial is testing

Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT

Who this might be right for
Myelodysplastic SyndromeAcute Leukemia
Peking University People's Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06299462
What this trial is testing

PTCy and ATG for MSD and MUD Transplants

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+2 more
Instituto Nacional de Cancer, Brazil 50
Testing effectiveness (Phase 2)Looking for participantsNCT03852407
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Who this might be right for
Acute Myeloid Leukemia in RemissionMyelodysplastic SyndromesChronic Myeloid Leukemia in Remission+7 more
University of Liege 114
Testing effectiveness (Phase 2)Active Not RecruitingNCT04202835
What this trial is testing

ATG Plus PTCy vs ATG for CGVHD Prophylaxis

Who this might be right for
Acute LeukemiaMyelodysplasiaChronic Graft-versus-host-disease
McMaster University 80
Post-approval studies (Phase 4)UnknownNCT05634915
What this trial is testing

Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantationAcute Leukemia
The First Affiliated Hospital of Soochow University 90
Large-scale testing (Phase 3)Study completedNCT00655343
What this trial is testing

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

Who this might be right for
Graft vs Host Disease
Neovii Biotech 202
Testing effectiveness (Phase 2)Study completedNCT00822770
What this trial is testing

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 47
Post-approval studies (Phase 4)UnknownNCT03190733
What this trial is testing

A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT

Who this might be right for
Chronic Graft-versus-host-diseaseLeukemia Relapse
Zhujiang Hospital 192
Testing effectiveness (Phase 2)Ended earlyNCT00506948
What this trial is testing

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Who this might be right for
Hematological MalignanciesMyelodysplastic SyndromeLeukemia+1 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT06265584
What this trial is testing

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromeMyeloproliferative Disorders
University of Alabama at Birmingham 56
Testing effectiveness (Phase 2)Study completedNCT01390402
What this trial is testing

Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

Who this might be right for
LeukemiaChronic Myelogenous Leukemia
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00813124
What this trial is testing

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Large-scale testing (Phase 3)Not Yet RecruitingNCT06083129
What this trial is testing

Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor

Who this might be right for
GVHD
Assistance Publique - Hôpitaux de Paris 324
Not applicableUnknownNCT00093587
What this trial is testing

Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06315309
What this trial is testing

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

Who this might be right for
GVHD,AcuteAcute LeukemiaMyelodysplastic Syndromes+1 more
University of Alabama at Birmingham 29
Load More Results